Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Rhinomed Limited
  6. News
  7. Summary
    RNO   AU000000RNO1

RHINOMED LIMITED

(RNO)
SummaryChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Rhinomed : Receives CE Mark for Nasal Swab Product

05/20/2021 | 03:04am EDT


ę MT Newswires 2021
All news about RHINOMED LIMITED
09/13Rhinomed Limited Appoints Rhinoswab Distributors for Australia and Belgium, the Netherl..
CI
09/10RHINOMED : to Deliver One Million COVID-19 Nasal Swabs to Australia's Victoria Government
MT
09/09Rhinomed Limited Receives an Initial Purchase Order for One Million Rhinoswabs from the..
CI
08/26Rhinomed Limited Announces Ethics Approval Granted for Clinical Trial of First Nasal Sw..
CI
08/26Rhinomed Limited Reports Earnings Results for the Full Year Ended June 30, 2021
CI
08/10Rhinomed Limited Receives Purchase Orders and Begun Supplying NSW Health Pathology
CI
05/20RHINOMED : Receives CE Mark for Nasal Swab Product
MT
05/13Rhinomed Limited Announces the Appointment of Associate Professor John Mcbain AO as A N..
CI
05/13RHINOMED : Nasal Swab Product Achieves High Yields, Clinical Study Reveals
MT
05/12Rhinomed Limited Reports an Important Update on Its Rhinoswabô Clinical Program
CI
More news
Financials
Sales 2021 4,65 M 3,37 M 3,37 M
Net income 2021 -8,64 M -6,26 M -6,26 M
Net cash 2021 1,87 M 1,35 M 1,35 M
P/E ratio 2021 -4,56x
Yield 2021 -
Capitalization 91,4 M 66,7 M 66,2 M
EV / Sales 2020 2,44x
EV / Sales 2021 8,07x
Nbr of Employees -
Free-Float 10,1%
Chart RHINOMED LIMITED
Duration : Period :
Rhinomed Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends RHINOMED LIMITED
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Managers and Directors
Michael Johnson Chief Executive Officer, MD & Executive Director
Sean Slattery Chief Financial Officer & Secretary
Ronald R. Dewhurst Non-Executive Chairman
Brent J. Scrimshaw Independent Non-Executive Director
Eric Knight Independent Non-Executive Director
Sector and Competitors